Add this topic to your myFT Digest for news straight to your inbox
Pharmaceutical company formerly known as Valeant keeps shedding assets from past deal spree
Drugmaker’s shares climb 12% in early trading after earnings beat estimates
Pershing Square founder has lost his groove
Pharma business models have been disrupted in two short years
China plans to introduce a bond trading link between Hong Kong and the mainland
The hedge fund is right to cut its losses but the reputational damage is severe
The pharma group is emerging from a break-up with a former suitor in good shape
Glencore, Valeant, Airbnb, BT, and insurers facing higher asbestos payouts in the news
Share plunge highlights the puzzle of willing suspension of disbelief among investors
International Edition